Patents by Inventor Franklin G. Grosveld

Franklin G. Grosveld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5958684
    Abstract: The invention encompasses methods and reagents for the diagnosis of a disease caused by or associated with a gene having a somatic mutation giving rise to a frameshift mutation. The methods include the steps of providing a body fluid or tissue sample from a patient; and analyzing the sample for the presence of a gene having a frameshift mutation or a protein encoded thereby, wherein the presence of the mutated gene or encoded protein is indicative of the disease.
    Type: Grant
    Filed: October 2, 1996
    Date of Patent: September 28, 1999
    Inventors: Frederik Willem Van Leeuwen, Johannes Peter Henri Burbach, Franklin G. Grosveld
  • Patent number: 5538885
    Abstract: Expression systems which comprise a mammalian host, such as erythroid cells, transformed with a vector which comprises a promoter, a DNA sequence which codes for a desired polypeptide and a dominant control region. The vectors and methods for preparing polypeptides using the expression systems are also described. In a preferred embodiment, the vector contains cDNA for the desired polypeptide and a sequence which is capable of stabilising mRNA produced from the cDNA. The expression systems are particularly efficient and are capable of secreting the desired polypeptide.
    Type: Grant
    Filed: January 27, 1994
    Date of Patent: July 23, 1996
    Assignee: Imperial Chemical Industries PLC
    Inventors: Melvyn Hollis, Maurice R. C. Needham, Clare Gooding, Franklin G. Grosveld, Michael Antoniou
  • Patent number: 5532143
    Abstract: Vectors for the integration of a gene into genetic material of a mammalian host cell such that the gene may be expressed by the host cell comprise a promoter and the gene and include a dominant ectivator sequence capable of eliciting host cell-type restricted, integration site independent, copy number dependent expression of the gene.
    Type: Grant
    Filed: September 26, 1994
    Date of Patent: July 2, 1996
    Assignee: The Medical Research Council
    Inventors: Franklin G. Grosveld, Dimitris Kioussis